参考文献/References:
[1].Lawton JS,Tamis-Holland JE,Bangalore S,et al. 2021 ACC/AHA/SCAI Guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. J Am Coll Cardiol,2022,79(2):e21-e129.
[2].Werner GS,Martin-Yuste V,Hildick-Smith D,et al.EUROCTO trial investigators. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions[J]. Eur Heart J ,2018,39(26):2484-2493.
[3].Lee SW,Lee PH,Ahn JM,et al. Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion:the DECISION-CTO Trial[J]. Circulation,139(14):1674-1683.
[4].Obedinskiy AA,Kretov EI,Boukhris M,et al. The IMPACTOR-CTO Trial[J]. JACC Cardiovasc Interv,2018,11(13):1309-1311.
[5].Sapontis J,Salisbury AC,Yeh RW,et al. Early procedural and health status outcomes after chronic total occlusion?angioplasty: a report from the OPEN-CTO Registry (Outcomes,Patient Health Status,and Efficiency in Chronic Total Occlusion Hybrid Procedures)[J]. JACC Cardiovasc Interv,2017,10(15):1523-1534.
[6].Badoian AG,Krestyaninov OV,Khelimskii DA,et al. Predictors to quality of life improvements in patients with chronic coronary total occlusion depending on the selected treatment strategy[J]. Comp Iss Cardiovasc Dis,2021,10(2):72-83.
[7].Ybarra LF,Rinfret S,Brilakis ES,et al. Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies:CTO-ARC consensus recommendations[J]. Circulation,2021,143(5):479-500.
[8].Kalnins A,Strele I,LejnieksA. Comparison among different scoring systems in predicting procedural success and long-term outcomes after percutaneous coronary intervention in patients with chronic total coronary artery occlusions[J]. Medicina (Kaunas),2019,55(8):494.
[9].Almendarez M,Gurm HS,Mariani J,et al. Procedural strategies to reduce the incidence of contrast-induced acute kidney injury during percutaneous coronary intervention[J]. J Am Coll Cardiol Intv,2019,12(19):1878-1888.
[10].Vemmou E,Quadros AS,Dens JA,et al. In-stent CTO percutaneous coronary intervention: individual patient data pooled analysis of 4 multicenter registries[J]. J Am Coll Cardiol Intv,2021,14(12):1308-1319.
[11].Lamelas P,Padilla L,Abud M,et al. In-stent chronic total occlusion angioplasty in the LATAMCTO registry[J]. Catheter Cardiovasc Interv,2021,97(1):E34-E39.
[12].Galassi AR,Werner GS,Boukhris M,et al. Percutaneous recanalisation of chronic total occlusions:2019 consensus document from the EuroCTO Club[J]. EuroIntervention,2019,15(2):198-208.
[13].Brilakis ES,Mashayekhi K,Tsuchikane E,et al. Guiding principles for chronic total occlusion percutaneous coronary intervention[J]. Circulation,2019,140(5):420-433.
[14].Wu EB,Brilakis ES,Mashayekhi K,et al. Global chronic total occlusion crossing algorithm: JACC state-of-the-art review[J]. J Am Coll Cardiol,2021,78(8):840-853.
[15].Azzalini L,Alaswad K,Uretsky BF,et al. Multicenter experience with the antegrade fenestration and reentry technique for chronic total occlusion recanalization[J]. Catheter Cardiovasc Interv,2021,97(1):E40-E50.
[16].Tajti P,Xenogiannis I,Gargoulas F,et al. Technical and procedural outcomes of the retrograde approach to chronic total occlusion interventions[J]. EuroIntervention,2020,16(11):E891-E899.
[17].Matsuno S,Tsuchikane E,Harding SA,et al. Overview and proposed terminology for the reverse controlled antegrade and retrograde tracking (reverse CART) techniques[J]. EuroIntervention,2018,14(1):94-101.
[18].Vemmou E,Nikolakopoulos I,Xenogiannis I,et al. Recent advances in microcatheter technology for the treatment of chronic total occlusions[J]. Expert Rev Med Devices,2019,16(4):267-273.
[19].Maeremans J,Walsh S,Knaapen P,et al. The hybrid algorithm for treating chronic total occlusions in Europe: the RECHARGE registry[J]. J Am Coll Cardiol,2016,68(18):1958-1970.
[20].Wu EB,Tsuchikane E,Ge L,et al. Retrograde versus antegrade approach for coronary chronic total occlusion in an algorithm-driven contemporary Asia-Pacific Multicentre Registry: comparison of outcomes[J]. Heart Lung Circ,2020,29(6):894-903.
[21].Riley RF,Walsh SJ,Kirtane AJ,et al. Algorithmic solutions to common problems encountered during chronic total occlusion angioplasty:the algorithms within the algorithm[J]. Catheter Cardiovasc Interv,2019,93(2):286-297.
[22].Azzalini L,Carlino M. A new combined antegrade and retrograde approach for chronic total occlusion recanalization: facilitated antegrade fenestration and re-entry[J]. Catheter Cardiovasc Interv,2021,98(1):E85-E90.
[23].Wu EB,Tsuchikane E,Lo S,et al. Chronic total occlusion wiring: a state-of-the-art guide from the Asia Pacific Chronic Total Occlusion Club[J]. Heart Lung Circ,2019,28(10):1490-1500.
[24].Moroni F,Brilakis ES,Azzalini L. Chronic total occlusion percutaneous coronary intervention: managing perforation complications[J]. Expert Rev Cardiovasc Ther,2021,19(1):71-87.
[25].Hirai T,Grantham JA,Gosch KL,et al. Impact of subintimal or plaque modification on repeat chronic total occlusion angioplasty following an unsuccessful attempt[J]. J Am Coll Cardiol Intv,2020,13(8):1010-1012.
[26].Xenogiannis I,Choi JW,Alaswad K,et al. Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention[J]. Catheter Cardiovasc Interv,2020,96(5):1029-1035.
[27].Goleski PJ,Nakamura K,Liebeskind E,et al. Revascularization of coronary chronic total occlusions with subintimal tracking and reentry followed by deferred stenting:experience from a high-volume referral center[J]. Catheter Cardiovasc Interv,2019,93(2):191-198.
相似文献/References:
[1]韩培天 魏晓岩 杜彬彬 张津宁 王文州 郭艳娇 张克成 李春彦 李文慧.心肌缺血时间对STEMI患者急诊PCI术后早期左室舒张功能的影响及相关因素分析[J].心血管病学进展,2020,(6):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]
HAN Pei-tian,WEI Xiaoyan,DU Binbin,et al.Effect of Myocardial Ischemia Duration on Early Left Ventricular Diastolic Function in STEMI Patients After Emergency PCI and Analysis of Related Factors[J].Advances in Cardiovascular Diseases,2020,(2):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]
[2]贺彩红 荣晶晶 潘宏伟.定量血流分数在急性心肌梗死中的应用进展[J].心血管病学进展,2021,(4):347.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.014]
HE Caihong,RONG Jingjing,PAN Hongwei.Progress in the Application of Quantitative Flow Ratio in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2021,(2):347.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.014]
[3]陈佳仑 李树仁.不同策略血栓抽吸对于急性ST段抬高心肌梗死患者的研究进展[J].心血管病学进展,2021,(7):593.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.005]
CHEN Jialun,LI Shuren.Different Strategies of Thrombus Aspiration in Patients with Acute ST Elevation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2021,(2):593.[doi:10.16806/j.cnki.issn.1004-3934.2021.07.005]
[4]梁晨笛 秦纲.经皮冠状动脉介入诊疗中穿刺路径研究进展[J].心血管病学进展,2022,(3):232.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
LIANG Chendi,QIN Gang.Puncture Routes in Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2022,(2):232.[doi:10.16806/j.cnki.issn.1004-3934.2022.03.000]
[5]马兴鸿 汪蕾 方纬.核素心肌显像在冠状动脉慢性完全闭塞临床诊疗中的应用价值[J].心血管病学进展,2022,(4):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
MA Xinghong,WANG Lei,FANG Wei.Application Value of Radionuclide Myocardial Imaging In the Clinical Diagnosis And Treatment of Coronary Chronic Total Occlusion[J].Advances in Cardiovascular Diseases,2022,(2):313.[doi:10.16806/j.cnki.issn.1004-3934.2022.04.007]
[6]张爽 吴娜琼.腔内影像学在冠状动脉支架内再狭窄诊治应用中的研究进展[J].心血管病学进展,2022,(5):389.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.002]
ZHANG Shuang,WU Na qiong.Application of Intravascular Imaging in Diagnosis and Treatment of Coronary In-Stent Restenosis[J].Advances in Cardiovascular Diseases,2022,(2):389.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.002]
[7]管翔 王宇 张成糕 周健 张艺 李庆国.经皮心室辅助装置在复杂高危冠状动脉介入治疗中的应用进展[J].心血管病学进展,2022,(5):394.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.003]
GUAN Xiang,WANG Yu,ZHANG Chenggao,et al.Application Progress of Percutaneous Ventricular Assist Device in Complex High-Risk Coronary Intervention[J].Advances in Cardiovascular Diseases,2022,(2):394.[doi:10.16806/j.cnki.issn.1004-3934.2022.05.003]
[8]刘文 魏芳晶.药物涂层球囊在真性分叉病变中的研究进展[J].心血管病学进展,2022,(6):511.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.008]
LIU WenWEI Fangjing.Study of Drug-Coated?Balloon in?rue Coronary Bifurcation Lesions[J].Advances in Cardiovascular Diseases,2022,(2):511.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.008]
[9]宋艳华 来春林 杨五小.急性 ST段抬高型心肌梗死患者微血管功能障碍的研究进展[J].心血管病学进展,2022,(6):530.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.013]
SONG Yanhua,LAI Chunlin,YANG Wuxiao.Microvascular Dysfunction in Patients with Acute ST-Segment?levation Myocardial Infarction[J].Advances in Cardiovascular Diseases,2022,(2):530.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.013]
[10]纪欣强 王凡.肥胖悖论与经皮冠状动脉介入治疗预后相关性的研究进展[J].心血管病学进展,2022,(7):615.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
JI XinqiangWANG Fan.Correlation Between Obesity Paradox and Prognosis of Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2022,(2):615.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[11]赵林 李丹 张涛.正向夹层再入真腔技术在慢性完全闭塞病变介入治疗中的应用及临床预后评估[J].心血管病学进展,2023,(2):97.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.001]
ZHAO Lin,LI Dan,ZHANG Tao.Clinical Application and Prognosis of Antegrade Dissection Reentry Technique in Percutaneous Coronary Intervention for Chronic Total Occlusion Lesion[J].Advances in Cardiovascular Diseases,2023,(2):97.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.001]
[12]宋新星 马彦卓 刘文秀 孔令锋 彭育红 赵玉英 汝磊生.慢性完全闭塞病变逆向介入治疗技术进展[J].心血管病学进展,2023,(2):111.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.004]
SONG Xinxing,MA Yanzhuo,LIU Wenxiu,et al.Retrograde Coronary Chronic Total Occlusion Intervention[J].Advances in Cardiovascular Diseases,2023,(2):111.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.004]
[13]耿雪,集铄媛,刘德敏,等.冠状动脉慢性完全闭塞病变介入治疗的临床证据解读[J].心血管病学进展,2023,(2):116.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.005]
GENG Xue,JI Shuoyuan,LIU Demin,et al.Interpretation of Clinical Evidence of CTO-PCI[J].Advances in Cardiovascular Diseases,2023,(2):116.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.005]